On November 14th, Richluck Pharmaceutical stated on the investor interaction platform that the company currently has a production capacity of 8,000 tons/year of VC products and has planned to increase the production capacity of VC products to 0.02 million tons/year. According to statistics, in 2023, the company's VC product shipment volume has ranked among the top in the industry.
富祥药业：目前公司已具备8000吨/年的VC产品产能
jiangxi fushine pharmaceutical: Currently, the company has an annual production capacity of 8,000 tons of VC products.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated